FOLD
AMICUS THERAPEUTICS, INC.
undefined Pharmaceutical Preparations Large accelerated filer

Key Financials

Revenue
$634.2M
↑ 20.0%
Net Income
$-27110000
↑ 51.7%
Operating Income
$32.8M
↑ 31.8%
Gross Profit
$561.3M
↑ 18.1%
Total Assets
$949.9M
↑ 21.0%
EPS (Diluted)
$-0.09
↑ 50.0%
Total Liabilities
$675.6M
↑ 14.3%
Shareholders' Equity
$274.2M
↑ 41.3%

Recent SEC Filings

Form Type Filed Date Link
SCHEDULE 13G 5/14/2026 View on SEC
SCHEDULE 13G 5/11/2026 View on SEC
SCHEDULE 13G 5/7/2026 View on SEC
15-12G 5/7/2026 View on SEC
SCHEDULE 13G 5/1/2026 View on SEC
EFFECT 4/29/2026 View on SEC
EFFECT 4/29/2026 View on SEC
EFFECT 4/29/2026 View on SEC
EFFECT 4/29/2026 View on SEC
EFFECT 4/29/2026 View on SEC

Company Information

Field Value
Ticker FOLD
Company Name AMICUS THERAPEUTICS, INC.
CIK 1178879
Sector Pharmaceutical Preparations
Industry Large accelerated filer
SIC Code 2834
SIC Description Pharmaceutical Preparations
Entity Type operating
Fiscal Year End 1231
State of Incorporation DE
Phone (609) 662-2000